POST-ACUTE COVID-19
Clinical trials for POST-ACUTE COVID-19 explained in plain language.
Never miss a new study
Get alerted when new POST-ACUTE COVID-19 trials appear
Sign up with your email to follow new studies for POST-ACUTE COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a 5-Day pill ease the burden of long COVID?
Disease control OngoingThis study is testing whether a short course of an antiviral medication called ensitrelvir can help people with Long COVID feel better. About 40 adults with Long COVID symptoms lasting at least 60 days will take either the real pill or a placebo for 5 days. Researchers will measu…
Matched conditions: POST-ACUTE COVID-19
Phase: PHASE2 • Sponsor: Timothy Henrich • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
Could a single infusion ease the burden of long COVID?
Disease control OngoingThis study is testing whether a one-time infusion of a lab-made antibody (AER002) can help people with Long COVID feel better. About 30 adults with persistent symptoms after a COVID-19 infection will receive either the antibody treatment or a placebo. Researchers will track chang…
Matched conditions: POST-ACUTE COVID-19
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC